Vitamin B4 (Choline Chloride 60%) CFR Los Angeles rose in January on nutraceutical demand and export-compliance costs, even as trans-Pacific freight eased. Early-month documentation and testing charges to meet validation requirements lifted seller offers, with a mid-month freight blip temporarily lifting landed costs. Despite stable production and smooth port flows, lean West Coast stocks kept importers replenishing rather than drawing down, allowing origin increases to transmit into CFR quotes during the health-season buying window. Nutraceuticals provided the strongest demand pull as contract manufacturers maintained forward purchasing for winter immunity lines, and online retail channels reported robust orders. Dietary-supplement demand grew year on year, supporting restocking. Chinese and Indian contract manufacturers operated normally but faced higher batch-release expenses tied to validation protocols, pressuring free-on-board values, and sustaining the price move upward. Freight tightened late in the month, though logistics remained orderly. Looking ahead, easing is forecast, with a small decline into February, contingent on market conditions and seasonal restocking pressures.
